Thus, we have evidence for a specific pathway of activation in mononuclear phagocytes (CXCL12-stimulated Mø release of HB-EGF) that may match the specific biological properties of some cancers (HeLa, DLD-1 and metastatic colon cancer). This evidence concerns the gene CXCL12 and cancer.